Glycoprotein-130 Expression Is Associated With Aggressive Bladder Cancer and Is a Potential Therapeutic Target

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-1079
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Rac1 Is Correlated With Aggressiveness and a Potential Therapeutic Target for Gastric Cancer

International Journal of Oncology
Cancer ResearchOncology
2015English

Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2006English

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

CD147 Expression Is Associated With Tumor Proliferation in Bladder Cancer via GSDMD

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

High Expression of TFEB Is Associated With Aggressive Clinical Features in Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Loss of P63 Expression Is Associated With Tumor Progression in Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy